Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029392 · ClinicalTrials.gov registry record · Phase 3
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements
A Phase 3 study, sponsored by Corewell Health East.
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
NCT01029392 is a Phase 3 study that has completed, run by Corewell Health East. The registered enrollment target is 75 participants.
The verdict
NCT01029392, a Phase 3 study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
Study Summary
Our objective is to demonstrate that providing supplemental vitamin D to children with new onset DM will significantly decrease the levels of HbA1c and insulin requirement by the following methods. 1. Identify how often vitamin D levels are low in patients with new onset Type 1 diabetes mellitus (DM). 2. Record the hemoglobin A1c (HbA1c) level (which reflects the average blood sugar level over the past few months) and document insulin requirements before and after vitamin supplementation is given. Hypothesis: Maintaining vitamin D levels \>30 ng/ml will decrease HbA1c and insulin requirements.
Interventions
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01029392
The ClinicalTrials.gov registry entry for NCT01029392 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D is the first listed.
NCT01029392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01029392 about?
NCT01029392 is a clinical study titled "Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements". Our objective is to demonstrate that providing supplemental vitamin D to children with new onset DM will significantly decrease the levels of HbA1c and insulin requirement by the following methods. 1. Identify how often vitamin D levels are low in patients with new onset Type 1 diabetes mellitus (D...
What is the current status of trial NCT01029392?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2009-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01029392?
The interventions under investigation include: Vitamin D (DRUG).
Who is sponsoring clinical trial NCT01029392?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.